Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Income from Continuing Operations (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Income from Continuing Operations for 7 consecutive years, with 22486000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 54.55% to 22486000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 158687000.0 through Dec 2025, up 9.07% year-over-year, with the annual reading at 158687000.0 for FY2025, 9.07% up from the prior year.
  • Income from Continuing Operations hit 22486000.0 in Q4 2025 for Harmony Biosciences Holdings, down from 50865000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 87943000.0 in Q3 2022 to a low of 9620000.0 in Q3 2021.
  • Historically, Income from Continuing Operations has averaged 31783950.0 across 5 years, with a median of 31892500.0 in 2023.
  • Biggest YoY gain for Income from Continuing Operations was 52385.19% in 2021; the steepest drop was 603.93% in 2021.
  • Year by year, Income from Continuing Operations stood at 22714000.0 in 2021, then surged by 113.56% to 48509000.0 in 2022, then tumbled by 72.81% to 13188000.0 in 2023, then skyrocketed by 275.15% to 49475000.0 in 2024, then crashed by 54.55% to 22486000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for HRMY at 22486000.0 in Q4 2025, 50865000.0 in Q3 2025, and 39776000.0 in Q2 2025.